Merrill Lynch Far East Limited

start date:
end date:
Performance period years

Role: Sponsor

This is a one-time role. Returns are from the appointment date to the earliest of the end of the specified performance period and the last trading date. CAGR is the annualised return and is not shown for periods under 180 days. Relative returns are to the Tracker Fund of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.

Some data are hidden to fit your display. Rotate?

Client Added Total
return		 CAGR
total
return		 CAGR
relative
return
1 Ascentage Pharma Group International 2019-10-16 -27.26% -27.28% -23.30%
2 Blue Moon Group Holdings Limited 2020-12-04 -48.81% -48.83% -43.99%
3 China Literature Limited 2017-10-26 -53.86% -53.88% -50.91%
4 Everest Medicines Limited 2020-09-25 -36.84% -36.94% -40.33%
5 FOXCONN INTERCONNECT TECHNOLOGY LIMITED 2017-06-29 15.63% 15.64% 3.35%
6 Frontage Holdings Corporation 2019-05-17 21.79% 21.81% 40.06%
7 GUOTAI JUNAN SECURITIES CO., LTD. 2017-03-28 13.64% 13.65% -14.17%
8 Hangzhou Tigermed Consulting Co., Ltd. 2020-07-28 33.22% 33.35% 21.36%
9 HBM Holdings Limited (KY) 2020-11-30 -24.41% -24.42% -19.09%
10 JD Health International Inc. 2020-11-26 -38.36% -38.38% -34.49%
2020-11-26 -50.35% -51.85% -49.68%
11 Kangji Medical Holdings Limited 2020-06-16 -50.42% -50.45% -59.75%
12 Kuaishou Technology 2021-01-26 -70.12% -70.24% -65.50%
2021-01-26 -0.76% -0.79% 3.66%
13 Maoyan Entertainment 2019-01-23 -13.11% -13.12% -11.93%
14 Meituan 2018-09-07 6.68% 6.68% 6.63%
2018-09-07 -19.43% -20.18% -16.59%
15 New Century Healthcare Holding Co. Limited 2016-12-30 42.31% 42.35% -0.89%
16 SCE Intelligent Commercial Management Holdings Limited 2021-06-21 -59.75% -59.98% -49.57%
17 Shanghai Henlius Biotech, Inc. 2019-09-12 -2.63% -2.63% 4.95%
18 Topsports International Holdings Limited 2019-09-26 22.63% 22.65% 26.45%
19 WuXi Biologics (Cayman) Inc. 2017-05-31 213.27% 213.52% 155.37%
Average -5.88% -9.93%

Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top